Table 1.
Characteristics | No. | Mean or % | |
---|---|---|---|
Age (years) | Mean | 491 | 25.9 [25.4-26.4] |
< 20 | 47 | 9.6 | |
20-30 | 303 | 61.7 | |
≥ 30 | 141 | 28.7 | |
Gestational age (weeks) | Mean | 464 | 39.5 [39.1-39.8] |
≥ 37 | 430 | 92.7 | |
< 37 | 34 | 7.3 | |
BMI (kg/m²) | Mean | 454 | 24.4 [24.1-24.7] |
≥ 20 | 435 | 95.8 | |
< 20 | 19 | 4.2 | |
Gravidity (%) | Primigravidae | 91 | 18.5 |
Secundigravidae | 92 | 18.8 | |
Multigravidae | 308 | 62.7 | |
Ethnic group (%) | Aïzo | 305 | 62.1 |
Fon | 126 | 25.7 | |
Others | 60 | 12.2 | |
Residence area (%) | Sekou | 320 | 65.1 |
Attogon | 101 | 20.6 | |
Allada | 70 | 14.3 | |
Marital situation (%) | Maried | 482 | 98.2 |
Single | 9 | 1.8 | |
Education (%) | No | 328 | 66.8 |
Yes | 163 | 33.2 | |
IPTp group* (%) | SP | 173 | 35.2 |
MQFD | 169 | 34.4 | |
MQSD | 149 | 30.4 |
BMI: Body Mass Index (weight in kilograms divided by the square of the height in meters (kg/m²).
IPTp: Intermittent Preventive Treatment in Pregnancy (allocation group of MiPPAD trial)
SP: Sulfadoxine Pyrimethamine, MQFD: Mefloquine full dose, MQSD: Mefloquine split dose
95% Confidence Interval are in parentheses